Pharmaceuticals, Biotechnology and Life Sciences
Swedish Orphan Biovitrum has gained reimbursement for Ravicti, a new therapy option for the treatment of patients with Urea Cycle…
Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…
Hikma Pharmaceuticals’s wholly owned US subsidiary West-Ward Pharmaceuticals, has launched Ritonavir Tablets USP, 100 mg, the first AB-rated generic to…
BD said Monday today it will divest its remaining, minority stake in Vyaire Medical to funds managed by Apax Partners for $435…
The results reported by Cidara Therapeutics, for its lead antifungal candidate rezafungin acetate, which met all of its primary objectives,…
Boehringer Ingelheim’s nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease (SSc-ILD), has been put to the fast…
Baxter International has completed the acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is…
Matinas BioPharma has appointed Jerome D. Jabbour, Co-founder and President of Matinas, as its Chief Executive Officer (“CEO”) and a…
Johnson & Johnson has received a binding offer from Platinum Equity, a private investment firm, to acquire its LifeScan business…
Joe Wiley, CEO of Amryt, said Amryt has an ambitious plans for the remainder of 2018 as it looks forward to…